AnalystsKarl ChalabalaKarl Chalabala's Stock Forecasts
AnalystsKarl Chalabala
Sectors:
Industries:
Analyst Ranking
Top 43%
#2257 out of 5298 analysts
Average Return
+6.85%
Win Rate
38%3 out of 8
Risk vs Reward
Poor
Good
Karl Chalabala's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Amicus Therapeutics IncFOLD | +117.24% | $6.67 | $14.49 | 2025-05-02 - 2026-04-27 | Strong Buy |
Comstock Resources IncCRK | +29.95% | $6.61 | $8.59 | 2017-08-13 - 2018-08-14 | Strong Buy |
Amicus Therapeutics IncFOLD | +4.81% | $12.68 | $13.29 | 2023-03-01 - 2024-03-01 | Strong Buy |
Karl Chalabala Analyst Color
Get additional color on Karl Chalabala's coverage of popular stocks
Karl Chalabala's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Amicus Therapeutics IncFOLD | 6 | Strong Buy | $22.00 | N/A | Maintains | a year ago |
Southern Copper CorpSCCO | 1 | Strong Sell | $49.90 | N/A | Maintains | 3 years ago |
Gulfport Energy CorpGPOR | 1 | Strong Buy | $18.00 | N/A | Maintains | 9 years ago |
Comstock Resources IncCRK | 1 | Strong Buy | $12.00 | N/A | Maintains | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.